Used as a key intermediate in the synthesis of kinase inhibitors, particularly in the development of anticancer agents. Its structure allows selective binding to ATP sites in protein kinases, making it valuable in targeted therapies for leukemia and solid tumors. Also employed in the preparation of JAK2 and EGFR inhibitors. Widely applied in medicinal chemistry for optimizing potency and selectivity in drug candidates.